Nutex Health, Inc. Fundamental Analysis (NASDAQ: NUTX)
Nutex Health, Inc. Fundamental Analysis (NASDAQ: NUTX)
Nutex Health, Inc. (NASDAQ: NUTX) shows strong financial fundamentals with a PE ratio of 7.87, profit margin of 20.68%, and ROE of 43.76%. The company generates $0.8B in annual revenue with strong year-over-year growth of 82.36%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 91.6/100 based on profitability, valuation, growth, and balance sheet metrics. The A grade reflects excellent fundamentals and strong overall stability.
Fundamental Health Score
We analyze NUTX's fundamental strength across five key dimensions:
Efficiency Score
ExcellentNUTX demonstrates superior asset utilization.
Valuation Score
ExcellentNUTX trades at attractive valuation levels.
Growth Score
ModerateNUTX shows steady but slowing expansion.
Financial Health Score
ExcellentNUTX maintains a strong and stable balance sheet.
Profitability Score
ExcellentNUTX achieves industry-leading margins.
Key Financial Metrics
Is NUTX Expensive or Cheap?
P/E Ratio
NUTX trades at 7.87 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, NUTX's PEG of 0.36 indicates potential undervaluation.
Price to Book
The market values Nutex Health, Inc. at 2.95 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 3.51 times EBITDA. This is generally considered low.
How Well Does NUTX Make Money?
Net Profit Margin
For every $100 in sales, Nutex Health, Inc. keeps $20.68 as profit after all expenses.
Operating Margin
Core operations generate 39.04 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $43.76 in profit for every $100 of shareholder equity.
ROA
Nutex Health, Inc. generates $15.95 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Nutex Health, Inc. generates strong operating cash flow of $258.40M, reflecting robust business health.
Free Cash Flow
Nutex Health, Inc. generates strong free cash flow of $252.05M, providing ample flexibility for dividends, buybacks, or growth.
FCF Per Share
Each share generates $36.81 in free cash annually.
FCF Yield
NUTX converts 19.56% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
7.87
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.36
vs 25 benchmark
P/B Ratio
Price to book value ratio
2.95
vs 25 benchmark
P/S Ratio
Price to sales ratio
1.61
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.84
vs 25 benchmark
Current Ratio
Current assets to current liabilities
4.76
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.44
vs 25 benchmark
ROA
Return on assets percentage
0.16
vs 25 benchmark
ROCE
Return on capital employed
0.35
vs 25 benchmark
How NUTX Stacks Against Its Sector Peers
| Metric | NUTX Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 7.87 | 31.47 | Better (Cheaper) |
| ROE | 43.76% | 507.00% | Weak |
| Net Margin | 20.68% | -4103644.00% (disorted) | Strong |
| Debt/Equity | 0.84 | 0.00 | Distorted |
| Current Ratio | 4.76 | 5.79 | Strong Liquidity |
| ROA | 15.95% | -262.00% (disorted) | Strong |
NUTX outperforms its industry in 4 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Nutex Health, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
115.48%
Industry Style: Defensive, Growth, Innovation
High GrowthEPS CAGR
-54.93%
Industry Style: Defensive, Growth, Innovation
DecliningFCF CAGR
93.13%
Industry Style: Defensive, Growth, Innovation
High Growth